Brought to you by 
Idun grosses $27mm in first close of venture round
19 Oct 2005
Executive Summary
Idun Pharmaceuticals (therapeutics to control apoptosis) raised $27mm with the first part of a $65.6mm Series B venture financing of preferred stock. The second close (milestone-dependent) is expected late next year. Montgomery & Co. was the placement agent.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Idun grosses $27mm in first close of venture round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice